Lessin L - Search Results

1

The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS).

Rose EH, Abels RI, Nelson RA, McCullough DM, Lessin L. Rose EH, et al. Among authors: lessin l. Br J Haematol. 1995 Apr;89(4):831-7. doi: 10.1111/j.1365-2141.1995.tb08421.x. Br J Haematol. 1995. PMID: 7772519 Clinical Trial.

2

Clinical application of recombinant erythropoietin in myelodysplasia.

Mittelman M, Lessin LS. Mittelman M, et al. Among authors: lessin ls. Hematol Oncol Clin North Am. 1994 Oct;8(5):993-1009. Hematol Oncol Clin North Am. 1994. PMID: 7852220 Review.

3

Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulation.

Kurantsin-Mills J, Ibe BO, Natta CL, Raj JU, Siegel RS, Lessin LS. Kurantsin-Mills J, et al. Among authors: lessin ls. Br J Haematol. 1994 Jul;87(3):580-5. doi: 10.1111/j.1365-2141.1994.tb08316.x. Br J Haematol. 1994. PMID: 7993800

4

Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study.

Greenberg BR, Reynolds RD, Charron CB, Squillace KM, Lessin LS, Case DC Jr, Gams RA. Greenberg BR, et al. Among authors: lessin ls. Cancer. 1993 Mar 15;71(6):1989-92. doi: 10.1002/1097-0142(19930315)71:6<1989::aid-cncr2820710611>3.0.co;2-t. Cancer. 1993. PMID: 8443750 Clinical Trial.

5

Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.

Kurantsin-Mills J, Ofosu FA, Safa TK, Siegel RS, Lessin LS. Kurantsin-Mills J, et al. Among authors: lessin ls. Br J Haematol. 1992 Aug;81(4):539-44. doi: 10.1111/j.1365-2141.1992.tb02989.x. Br J Haematol. 1992. PMID: 1390242

6

High Ia (HLA-DR) and low CD11b (Mo1) expression may predict early conversion to leukemia in myelodysplastic syndromes.

Mittelman M, Karcher DS, Kammerman LA, Lessin LS. Mittelman M, et al. Among authors: lessin ls. Am J Hematol. 1993 Jul;43(3):165-71. doi: 10.1002/ajh.2830430302. Am J Hematol. 1993. PMID: 8352230 Review.

7

Oncogenes and growth factor genes in myelodysplasia.

Mittelman MM, Lessin LS. Mittelman MM, et al. Among authors: lessin ls. Hematol Pathol. 1991;5(1):37-41. Hematol Pathol. 1991. PMID: 2050604 Review. No abstract available.

8

Vaso-occlusion in sickle cell disease: pathophysiology of the microvascular circulation.

Kurantsin-Mills J, Klug PP, Lessin LS. Kurantsin-Mills J, et al. Among authors: lessin ls. Am J Pediatr Hematol Oncol. 1988 Winter;10(4):357-72. doi: 10.1097/00043426-198824000-00019. Am J Pediatr Hematol Oncol. 1988. PMID: 3071170 Review.

9

Irreversible erythrocyte volume expansion induced by tellurite.

Kurantsin-Mills J, Klug RK, Lessin LS. Kurantsin-Mills J, et al. Among authors: lessin ls. Br J Haematol. 1988 Nov;70(3):369-74. doi: 10.1111/j.1365-2141.1988.tb02496.x. Br J Haematol. 1988. PMID: 3207630

10

Flow dynamics of human sickle erythrocytes in the mesenteric microcirculation of the exchange-transfused rat.

Kurantsin-Mills J, Jacobs HM, Klug PP, Lessin LS. Kurantsin-Mills J, et al. Among authors: lessin ls. Microvasc Res. 1987 Sep;34(2):152-67. doi: 10.1016/0026-2862(87)90050-1. Microvasc Res. 1987. PMID: 3670112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters